Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666309 | SCV000790580 | pathogenic | Nephropathic cystinosis | 2017-03-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002530676 | SCV002238277 | pathogenic | Ocular cystinosis; Juvenile nephropathic cystinosis; Inborn genetic diseases | 2023-09-12 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 551289). This premature translational stop signal has been observed in individual(s) with cystinosis (PMID: 12825071, 26565940). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp297*) in the CTNS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTNS are known to be pathogenic (PMID: 9537412, 27102039). |
Baylor Genetics | RCV000666309 | SCV004212942 | pathogenic | Nephropathic cystinosis | 2023-09-29 | criteria provided, single submitter | clinical testing |